Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ringe

Showing results (311-320 of 316) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 316 results.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 16, 2014
Management of osteoporosis of the oldest oldR Rizzoli, J Branco, M-L Brandi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 17, 2013
Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trialClaus-C Glüer, Fernando Marin, Johann D Ringe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 7, 2013
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosisP Farahmand, F Marin, F Hawkins, et al.
Seminars in Arthritis and Rheumatism|August 9, 2005
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in ScienceEric C Abadie, Jean-Pierre Devogealer, Johann D Ringe, et al.
Molecular Psychiatry|August 8, 2012
Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brainJ W Steele, S Ju, M L Lachenmayer, et al.
Molecular Psychiatry|August 2, 2012
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse modelJ W Steele, M L Lachenmayer, S Ju, et al.
Pageof 32

Showing results (311-320 of 316) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 316 results.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 16, 2014
Management of osteoporosis of the oldest oldR Rizzoli, J Branco, M-L Brandi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 17, 2013
Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trialClaus-C Glüer, Fernando Marin, Johann D Ringe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 7, 2013
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosisP Farahmand, F Marin, F Hawkins, et al.
Seminars in Arthritis and Rheumatism|August 9, 2005
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in ScienceEric C Abadie, Jean-Pierre Devogealer, Johann D Ringe, et al.
Molecular Psychiatry|August 8, 2012
Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brainJ W Steele, S Ju, M L Lachenmayer, et al.
Molecular Psychiatry|August 2, 2012
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse modelJ W Steele, M L Lachenmayer, S Ju, et al.
Pageof 32